IP Library › Assignment 013751/0522
Patent Assignment
Reel/Frame 013751/0522

Change of Name

Recorded: 2003-02-13 Received: 2003-02-20 Pages: 13
Assignor
Assignee
ALTANA PHARMA AG
BYK-GULDEN-STRASSE 2, KONSTANZ, DEX, 78467, GERMANY
Covered Properties (24)
Tryptase Inhibitors
Application: 10/149,288 →
Tryptase Inhibitors
Application: 10/149,517 →
Combination of C1-Inh and Lung Surfactant for the Treatment of Respiratory Disorders
Application: 10/088,294 →
Ciclesonide Contained Pharmaceutical Composition for Application to Mucosa
Application: 10/110,629 →
Ciclesonide Containing Aqueous Pharmaceutical Composition
Application: 10/110,632 →
Phenanthridine-N-Oxides
Application: 10/149,965 →
Process and Intermediates for the Preparation of Imidazopyridines
Application: 10/149,290 →
Novel Tryptase Inhibitors
Application: 10/049,111 →
Tetrahydrothiopyranphthalazinone Derivatives as PDE4 Inhibitors
Application: 10/110,397 →
Phthalazinone Derivatives as PDE4 Inhibitors
Application: 10/110,460 →
Tryptase Inhibitors
Application: 10/070,279 →
Synergistic Combination
Application: 10/049,999 →
Synergistic Combination Comprising Roflumilast and a Pde-3 Inhibitor
Application: 09/959,599 →
Pharmaceutical preparation containing modifications of surfactant protein b(sp-b) and surfactant protein c (sp-c)
Application: 09/979,032 →
Surfactant Protein C Esters
Application: 09/959,628 →
Recombinant Sp-a for the Treatment or Prevention of Pulmonary Infection and Inflammation
Application: 09/889,348 →
3-Cyclopropylmethoxy-4-Difluoromethoxy-N-(3,5-Dichloropyrid-4-Yl)Benzamide in the Treatment of Multiple Sclerosis
Application: 09/914,763 →
6-Arylphenanthridines with Pde-Iv Inhibiting Activity
Application: 09/889,143 →
Phenanthridine-N-Oxides with Pde-Iv Inhibiting Activity
Application: 09/889,146 →
Phenylphennanthridines with Pde-Iv Inhibiting Activity
Application: 09/889,144 →
Polysubstituted 6-Phenylphenanthridines with Pde-Iv Inhibiting Activity
Application: 09/889,145 →
Phenanthridine-N-Oxides with Pde-Iv Inhibiting Activity
Application: 09/889,142 →
Treatment set containing lungsurfactant compositions
Application: 09/831,293 →
Blind Clinical Trial Device
Application: 09/830,427 →